학술논문
Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update
Document Type
Abstract
Author
Source
In Blood 8 December 2017 130 Supplement 1:900-900
Subject
Language
ISSN
0006-4971